[1]
Saqib Ali and Muhammad Affan Ilyas 2024. Fezolinetant- A novel NK3R antagonist for treating postmenopausal vasomotor symptoms. Journal of the Pakistan Medical Association. 74, 8 (Jul. 2024), 1582–1582. DOI:https://doi.org/10.47391/JPMA.20096.